Assessment of Pubertal Growth Spurt in Growing Girls Using Middle Phalynx Finger and Correlate With Mandibular Second Molar
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03363802|
Recruitment Status : Enrolling by invitation
First Posted : December 6, 2017
Last Update Posted : December 7, 2017
|Condition or disease|
The sample will be selected randomly from different schools in the government.
- Digital periapical radiograph for the middle finger for each participants will be taken using Digital x-ray portable machine.
- Radiographical images will be stored in a digital sensor to be transferred to computer then we asses growth spurt in girls and correlate it with devlopemt stage of mandibular second molar
|Study Type :||Observational|
|Estimated Enrollment :||1600 participants|
|Official Title:||Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar in Al Sharkia Governorate|
|Estimated Study Start Date :||February 10, 2018|
|Estimated Primary Completion Date :||March 2018|
|Estimated Study Completion Date :||April 2018|
- Assessment of the time of pubertal growth spurt in growing Egyptian [ Time Frame: 3month ]Taking xray of middle phalynx finger and then asses age of growth spurt through stages of middle phalynx finger
- females. Assessment the correlation between the modified middle phalanx of the middle finger and development stage of mandibular second molar [ Time Frame: 3month ]By taking xray mandibular second molar then make correlation between stages of both to estimate age for pubertal growth spurt for females
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03363802
|Zagazig, Sharkia Governorate, Egypt, 44661|